Defziff 1 Tablet contains Deflazacort 1mg, a glucocorticoid corticosteroid used to treat inflammatory and autoimmune conditions, allergies, and certain chronic illnesses. It works by suppressing the immune response, reducing inflammation, and alleviating associated symptoms such as pain, swelling, and redness.
This tablet is commonly prescribed for asthma, rheumatoid arthritis, lupus, dermatitis, and other autoimmune or inflammatory disorders, providing effective symptom control while minimizing side effects compared to traditional corticosteroids.
Defziff 1 Tablet belongs to the anti-inflammatory and immunosuppressive segment, frequently recommended by endocrinologists, rheumatologists, and general physicians.
For PCD pharma franchise partners, wholesalers, and exporters, Defziff 1 Tablet presents a high-demand opportunity due to the rising prevalence of autoimmune and inflammatory conditions. It is available for bulk supply, monopoly-based franchise, third-party manufacturing, institutional distribution, and export, ensuring consistent market demand and profitable business potential.